Search Results - PHARMACOECONOMICS

161

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation

by Dmitry Vladimirovich Goryachev, Sh F Erdes, E L Nasonov
Published 2010-04-01

Get full text

Article

162

Pharmacoeconomic analysis of various treatment regimens of Congo-Crimean hemorrhagic fever

by G. Abuova, N. Pshenichnaya, L. Ermakova, F. Berdalieva, B. Khodzhabekov, N. Golovchenko, A. Zhuravlev, L. Parolina
Published 2020-12-01

Get full text

Article

163

Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up

by Francesco Menzella, Nicola Facciolongo, Roberto Piro, Debora Formisano, Alberto Roggeri, Anna Simonazzi, Claudia Castagnetti, Cristiano Carbonelli, Luigi Zucchi
Published 2012-04-01

Get full text

Article

164

Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy

by Sudhir C. Sarangi, Nivendeep Kaur, Manjari Tripathi
Published 2020-10-01

Subjects: “...Pharmacoeconomic...”

Get full text

Article

165

Pharmacoeconomic effectiveness of lenvatinib in patients with differentiated radioiodine-resistant thyroid cancer

by S. K. Zyryanov, I. N. Dyakov
Published 2018-05-01

Subjects: “...pharmacoeconomics...”

Get full text

Article

166

Clinical and pharmacoeconomic aspects of anti-TNF therapy change for medical reasons

by U. S. Gushchina, S. K. Zyryanov, I. A. Orlikhina
Published 2018-05-01

“.... In this article, the available data on the impact of non-medical switching on the clinical and pharmacoeconomic...”

Get full text

Article

167

Pharmacoeconomic Evaluation of Pantoprazole and Pantoprazole Plus Domperidone in Treatment of Patients with GERD

by Rucha Ulhas Puranik, Yogita Surendra Karandikar, Shreepad Mukundrao Bhat, Vrushali Anil Patil
Published 2018-11-01

“... controversial. Aim: The study was conducted to perform pharmacoeconomic evaluation of Pantoprazole...”

Get full text

Article

168

Pharmacoeconomic evaluation of the ceftolosan + tasobactam in the treatment of complicated nosocomial intraabdominal infections

by I. N. Dyakov, S. K. Zyryanov, N. N. Khachatryan
Published 2019-10-01

Subjects: “...pharmacoeconomics...”

Get full text

Article

169

Pharmacoeconomic analysis of anti-VEGF therapy for age-related macular degeneration

by A. E. Cheberda, D. Yu. Belousov, M. M. Shishkin
Published 2018-05-01

Subjects: “...pharmacoeconomics...”

Get full text

Article

170

Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson’s disease

by D. Yu. Belousov, E. V. Afanasyeva
Published 2018-05-01

Subjects: “...pharmacoeconomics...”

Get full text

Article

171

On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers

by Andrea Carta, Claudio Conversano
Published 2020-10-01

Subjects: “...pharmacoeconomics...”

Get full text

Article

172

Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment

by Krzysztof Kowalik, Małgorzata Węgierska, Tacjana Barczyńska, Sławomir Jeka
Published 2018-12-01

Get full text

Article

173

Schizophrenia care: an overview considering family burden, medication adherence, and pharmacoeconomics

by Aswini B, Sreelakshmi Sreedhar, Neethu Poulose, PN Suresh Kumar
Published 2016-01-01

“..., such as family burden, medication adherence, and pharmacoeconomics. There are many interventions that should...”

Get full text

Article

174

Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy

by Sergio Iannazzo, Lorenzo Pradelli, Orietta Zaniolo
Published 2008-09-01

“...Objective: to evaluate pharmacoeconomic implications of the use of valsartan, an angiotensin II...”

Get full text

Article

175

Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension

by Frenkel Ronald EP, Frenkel Max, Toler Allison
Published 2007-09-01

Get full text

Article

176

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta

by Castrop F, Haslinger B, Hemmer B, Buck D
Published 2013-09-01

“... of the disease, it is very costly; therefore, pharmacoeconomics, evaluating costs and effects of disease...”

Get full text

Article

177

Conceptual foundations of pharmacoeconomic analysis of prevention technologies of chronic viral infections

by S. O. Soloviov, I. V. Dziublyk, V. V. Trokhymchuk
Published 2019-10-01

Subjects: “...pharmacoeconomics...”

Get full text

Article

178

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION

by A. V. Rudakova
Published 2015-09-01

“... was to describe pharmacoeconomic aspects of using apixaban for stroke and other cardiovascular events prevention...”

Get full text

Article

179

RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA

by T. Vekov
Published 2015-09-01

“...<p>The theoretical foundations of the application of pharmacoeconomic evaluations...”

Get full text

Article

180

PHARMACOECONOMIC EFFECTIVENESS OF SOME MODERN METHODS OF THERAPY IN CYSTIC FIBROSIS CHILDREN

by N.Yu. Kashirskaya, N.I. Kapranov, Yu.I. Vasil'eva
Published 2006-06-01

“...In the last years interest has been aroused to pharmacoeconomics — the economic evaluation...”

Get full text

Article

Narrow Search